Drug Screening Market Analysis by Product Type (Consumables, Instruments, Rapid Testing Devices, and Services); and by End User (Workplace, Hospital, and Criminal Justice) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2035
Buy Now Report ID: 4891 | Published Date: May 02, 2023
Drug Screening Market is estimated to garner a revenue of ~USD 63 billion by the end of 2035 by growing at a CAGR of ~19.80% over the forecast period, i.e., 2023 – 2035. Further, the market generated a revenue of ~USD 7 billion in the year 2023. The market growth is mainly owing to the increasing prevalence of drug abuse, the growing demand for drug testing in the workplace, and the rising number of drug testing laboratories and service providers. According to the World Drug Report 2021 by the United Nations Office on Drugs and Crime (UNODC), an estimated 275 million people worldwide used drugs at least once in the year 2020. This represents a 22% increase in the number of people who used drugs in the year 2010.
In addition to this, in terms of specific drugs, cannabis is the most commonly used drug worldwide, with an estimated 200 million users in 2020. The use of opioids, including heroin and prescription opioids, continues to be a major concern, with an estimated 53 million people using opioids in 2020. Additionally, the non-medical use of prescription stimulants such as amphetamines is on the rise. Overall, the increasing prevalence of drug abuse highlights the importance of drug screening and testing in various settings to prevent drug-related harm and promote public health and safety. Drug screening tests are commonly used in various settings, including workplaces, hospitals, and law enforcement agencies. These tests can detect a wide range of drugs, including marijuana, cocaine, opioids, amphetamines, and others. They can be performed using different methods, such as urine, saliva, blood, and hair testing.
|
Base Year |
2022 |
|
Forecast Year |
2023-2035 |
|
CAGR |
~19.80% |
|
Base Year Market Size (2023) |
~ USD 7 Billion |
|
Forecast Year Market Size (2035) |
~ USD 63 Billion |
|
Regional Scope |
|
Growth Drivers
Challenges
The global industry is segmented and analyzed for demand and supply by end user into workplace, hospital, and criminal justice. Out of the three types of end users, the hospital segment is estimated to gain the largest market share of about ~35% in the year 2035. The growth of the segment can be accredited to the presence of a large number of patients in the hospitals, which is expanding notably. The hospitals are also growing rapidly in number. For instance, by the year 2022, there were noted to be approximately 6,100 hospitals in the United States. Hospitals provide a wide range of medical care. Physicians, called hospital doctors, typically specialize in internal medicine, pediatrics, or general practice. They have the knowledge to solve common problems and the resources to solve more complex medical problems. Hospitals may also offer specialized care, such as neurology, obstetrics and gynecology, and oncology. By definition of a hospital, a county hospital is typically a primary medical facility in a region with numerous intensive care and mobile beds for patients requiring long-term care.
The global drug screening market is also segmented and analyzed for demand and supply by product type into consumables, instruments, rapid testing devices, and services. Amongst these four segments, the rapid testing devices segment is expected to garner a significant share of around ~30% in the year 2035. The growth of the segment can be accredited to the increasing demand for drug screening. The demand for drug screening is increasing across various industries, including healthcare, sports, and government agencies. Rapid testing devices provide a quick and easy way to screen individuals for drugs, making them an attractive option for these industries. Drug abuse is a global problem that affects individuals from all walks of life. The increasing prevalence of drug abuse has led to a greater need for drug screening, which is expected to drive the growth of the rapid testing devices segment. Rapid testing devices have undergone significant technological advancements in recent years, resulting in improved accuracy and sensitivity. These advancements have made rapid testing devices a more reliable and effective option for drug screening. Overall, the rapid testing devices segment in the global drug screening market is expected to grow owing to increasing demand, growing prevalence of drug abuse, technological advancements, cost-effectiveness, and government initiatives.
Our in-depth analysis of the global drug screening market includes the following segments:
|
By End User |
|
|
By Product Type |
|
The drug screening in the Asia Pacific region, amongst the market in all the other regions, is projected to hold the largest market share of about ~35% by the end of 2035. The regional growth can majorly be attributed to the rising awareness about drug screening. The Asia Pacific region has witnessed a significant increase in the prevalence of drug abuse in recent years. According to a report by the United Nations Office on Drugs and Crime (UNODC), the prevalence of drug abuse in Asia increased from 2.3% in 2009 to 3.3% in the year 2019. There is a growing awareness of the importance of drug screening in the Asia Pacific region. This has led to an increase in demand for drug screening services, including rapid testing devices. Governments in the Asia Pacific region are taking steps to combat drug abuse by implementing drug screening programs in various industries. For instance, in 2019, the Malaysian government announced that it would introduce mandatory drug screening for all foreign workers. Similarly, the Indian government has launched a national program to conduct drug screening tests for truck drivers. Overall, the drug screening market in the Asia Pacific region is expected to grow owing to the growing prevalence of drug abuse, rising awareness about drug screening, government initiatives, increasing investments, and technological advancements.
The drug screening in the North American region, amongst the market in all the other regions, is projected to hold the second largest share of about ~24% during the forecast period. The growth of the market in this region can primarily be attributed to the stringent government regulations. The North American region has stringent government regulations for drug screening in various industries, such as transportation and healthcare. These regulations are expected to drive the growth of the drug screening market in the region. For instance, the U.S. Department of Transportation (DOT) requires drug and alcohol testing for all commercial drivers. There is a growing awareness of the impact of drug abuse on society, which has led to an increase in demand for drug screening services. The drug screening industry has witnessed significant technological advancements in recent years, resulting in improved accuracy and sensitivity of drug screening tests. This has made drug screening a more reliable and effective option for various industries in the North American region. Overall, the drug screening market in North America is expected to grow owing to stringent government regulations, increasing awareness about drug abuse, technological advancements, increasing investments, and growing demand for workplace drug testing.
Further, drug screening in the Europe region, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2035. The growth of the market can be attributed majorly to the increasing prevalence of drug abuse in the region. Europe has witnessed a significant increase in the prevalence of drug abuse in recent years. According to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), around 24 million adults (aged 15-64) in Europe used illicit drugs in 2019. The drug screening industry in Europe is highly regulated, with strict regulations for drug testing in various industries. For instance, the European Commission has set standards for drug testing in the transportation industry, including mandatory drug and alcohol testing for commercial drivers. This has also led to the adoption of new drug testing technologies, such as oral fluid and hair testing. Overall, the drug screening market in Europe is expected to grow owing to the increasing prevalence of drug abuse, stringent regulations, growing awareness about drug testing, technological advancements, and increasing investments.
In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.
Author Credits: Radhika Gupta, Shivam Bhutani
Ans: Increasing prevalence of drug abuse, and stringent government regulations are the major factors driving the market growth.
Ans: The market size of drug screening is anticipated to attain a CAGR of ~19.80% over the forecast period, i.e., 2023 – 2035.
Ans: The variability in drug test results is estimated to be the growth hindering factor for the market expansion.
Ans: The market in the Asia Pacific region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Ans: The major players in the market are Shimadzu Corporation, F. Hoffmann-La Roche AG, Express Diagnostics International Inc., OraSure Technologies, Drägerwerk AG & Co. KGaA, and others.
Ans: The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.
Ans: The market is segmented by product type, end users, and by region.
Ans: The hospital segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Submit Your Request For Proposal (RFP)
